Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000128336 | SCV000171929 | benign | not specified | 2013-11-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000310983 | SCV000432152 | uncertain significance | Mitochondrial DNA depletion syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000356495 | SCV000432153 | uncertain significance | Mitochondrial DNA depletion syndrome 9 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000356495 | SCV001018827 | benign | Mitochondrial DNA depletion syndrome 9 | 2025-01-24 | criteria provided, single submitter | clinical testing | |
Elsea Laboratory, |
RCV000356495 | SCV001424293 | likely benign | Mitochondrial DNA depletion syndrome 9 | 2020-04-01 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV001529336 | SCV001742608 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000128336 | SCV001967996 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004757133 | SCV005352081 | benign | SUCLG1-related disorder | 2024-08-05 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |